Evidence map›Paper›PMID 26951286›Full record

ReviewJournal of general internal medicine2016

Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.

G Michael Allan, Lynda Cranston, Adrienne Lindblad, James McCormack, Michael R Kolber, Scott Garrison, Christina Korownyk

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of general internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Osteoporosis in rheumatoid arthritis: a new perspective on risk factors and clinical prediction models.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The effect of zoledronic acid and high-dose vitamin D on function after hip fractures. A prospective cohort study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2022
    Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. The evident and the hidden factors of vitamin D status in older people during COVID-19 pandemic.Nutrire : revista de Sociedade Brasileira de Alimentacao e Nutricao = journal of the Brazilian Society of Food and Nutrition · 2021
    Review
  14. Insufficiency of B vitamins with its possible clinical implications.Journal of clinical biochemistry and nutrition · 2020
    Review
  15. Review
  16. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis.Calcified tissue international · 2020
    Review
  17. Article
  18. Photobiomodulation: lasers vs. light emitting diodes?Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2018
    Article
  19. Article
  20. Vitamin D: Ten Beliefs.Journal of general internal medicine · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

G Michael AllanEvidence-Based Medicine, Department of Family Medicine - Research Program, University of Alberta, 6-10 University Terrace, Edmonton, AB, T6G 2T4, Canada. michael.allan@ualberta.ca.
Lynda CranstonThe Foundation for Medical Practice Education, Hamilton, ON, Canada.
Adrienne LindbladEvidence-Based Medicine, Department of Family Medicine - Research Program, University of Alberta, 6-10 University Terrace, Edmonton, AB, T6G 2T4, Canada.
James McCormackFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Michael R KolberEvidence-Based Medicine, Department of Family Medicine - Research Program, University of Alberta, 6-10 University Terrace, Edmonton, AB, T6G 2T4, Canada.
Scott GarrisonEvidence-Based Medicine, Department of Family Medicine - Research Program, University of Alberta, 6-10 University Terrace, Edmonton, AB, T6G 2T4, Canada.
Christina KorownykEvidence-Based Medicine, Department of Family Medicine - Research Program, University of Alberta, 6-10 University Terrace, Edmonton, AB, T6G 2T4, Canada.
University of Alberta · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, a large body of observational evidence has suggested an association between lower vitamin D status (25-hydroxyvitamin D) and multiple acute and chronic disorders, including cancer, multiple sclerosis, depression and respiratory tract infections. This evidence has fostered the hypothesis that increasing vitamin D intake may treat and prevent such disorders. Our objective was to perform a critical analysis of the highest-level evidence for ten common beliefs regarding vitamin D for the prevention of falls, fractures and respiratory tract infections, the reduction of cancer incidence/mortality and overall mortality, and the prevention or treatment of depression/mental well-being, rheumatoid arthritis and multiple sclerosis, as well as maximum dosing and regular testing. We searched the Cochrane Database of Systematic Reviews and PubMed (up to August 2014) for randomized controlled trials and systematic reviews/meta-analyses based on those studies. All searches were performed, all evidence reviewed and each section written by at least two authors. The evidence shows that vitamin D supplementation provides some benefit in fracture prevention (likely ∼10-15 % relative reduction), particularly at a dose ≥800 IU and with calcium; a likely benefit in the rate of falls, though it is less clear whether the number of fallers changes; and a possible small (∼5 %) relative reduction in mortality. Evidence does not support the use of vitamin D supplementation for the prevention of cancer, respiratory infections or rheumatoid arthritis. Similarly, evidence does not support vitamin D supplementation for the treatment of multiple sclerosis and rheumatoid arthritis or for improving depression/mental well-being. Regular testing of 25-hydroxyvitamin D is generally not required, and mega-doses (≥300,000 IU) appear to increase harms. Much of the evidence is at high risk of bias, with multiple flaws, including analyses of secondary endpoints, small and underpowered studies, inconsistent results and numerous other issues. Therefore, enthusiasm for a vitamin D panacea should be tempered.

Indexed as

Accidental FallsDietary SupplementsDose-Response Relationship, DrugFractures, BoneHumansMeta-Analysis as TopicMortalityObservational Studies as TopicProspective StudiesRandomized Controlled Trials as TopicVitamin DVitamins25-hydroxyvitamin DVitamin DVitaminsdepressionfallsfracturemortalityupper respiratory tract infectionvitamin D

Identifiers

PMID26951286
PMCPMC4907952
OpenAlexW2320817362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.